Results 251 to 260 of about 95,044 (332)
From Liver Insights to Lung Innovations: FGF21 and Idiopathic Pulmonary Fibrosis. [PDF]
Am J Respir Crit Care MedGonzalez Coba AJ, Barnes JW, Krick S.
europepmc +1 more source
Clinical and Translational Allergy, Volume 15, Issue 4, April 2025.Abstract Background Hypoxia is a prevalent pathological process in chronic rhinosinusitis with nasal polyps (CRSwNP), leading to a cascade of pathological events, including epithelial‐mesenchymal transition (EMT). However, the mechanisms underlying hypoxia‐induced EMT remain unclear. This study aims to elucidate the mechanisms driving EMT under hypoxic
Sicen Pan +7 more
wiley +1 more source
Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis
, 2003 Keisuke Miki +6 more
openalex +1 more source
Identification and validation of CDC20 and ITCH as ubiquitination related biomarker in idiopathic pulmonary fibrosis. [PDF]
HereditasSun S, Wang Y, Feng J.
europepmc +1 more source
Progress, Pitfalls, and Impact of AI‐Driven Clinical Trials
Clinical Pharmacology &Therapeutics, Volume 117, Issue 4, Page 887-890, April 2025.Since the deep learning revolution of the early 2010s, significant efforts and billions of dollars have been invested in applying artificial intelligence (AI) to drug discovery and development (AIDD). However, despite high expectations, few AI‐discovered or AI‐designed drugs have entered human clinical trials, and none have achieved clinical approval ...
Dominika Wilczok, Alex Zhavoronkov
wiley +1 more source
Blood Cell Counts and Inflammatory Indexes in Idiopathic Pulmonary Fibrosis. [PDF]
CureusAy D +5 more
europepmc +1 more source
Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
Clinical and Translational Medicine, Volume 15, Issue 4, April 2025.1. In theory, CAR‐engineering therapy can achieve therapeutic effects by targeting cells expressing specific antigens and thereby eliminating or regulating disease‐related cell subpopulations. 2. Although CAR‐engineering therapy is currently only approved for the treatment of cancer, it has also shown potential in non‐tumour diseases. 3.
Lvying Wu, Lingfeng Zhu, Jin Chen
wiley +1 more source
A Clinical Study of Idiopathic Pulmonary Fibrosis Based on Autopsy Studies in Elderly Patients
, 2003 Takehiko Araki +3 more
openalex +2 more sources
Recent progress in exosomal non-coding RNAs research related to idiopathic pulmonary fibrosis. [PDF]
Front GenetWei Y, Hong M, Zhu H, Li F.
europepmc +1 more source